mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Optimal range of HbA1c for the prediction of future diabetes: A 4-year longitudinal study

Bae JC et al. – A HbA1c cut–point of 5.7% is a suitable value for predicting future diabetes. It is reasonable to consider a HbA1c range of 5.7–6.4% as a category of increased risk for diabetes in Korean, similar to an IFG or IGT.

Methods
  • A retrospective analysis was conducted among subjects who participated in comprehensive health check–ups annually for 5 years.
  • A total of 9723 subjects were classified into 12 categories based on the baseline HbA1c level.

Results
  • During 4 years, 601 of the 9723 subjects (6.2%) developed diabetes.
  • Based on ROC analysis, a HbA1c of 5.7% gave an optimal sensitivity of 62% and specificity of 85% to predict diabetes.
  • The point showing a substantial difference in the Kaplan–Meier curves was a HbA1c of 5.7%.
  • The incidence of diabetes was 20.8% among subjects with a baseline HbA1c of 5.7–6.4%.
  • The hazard ratio of developing diabetes was 6.5 (95% CI, 3.7–10.2) in the subjects with a HbA1c of 5.7% compared with the bottom category of HbA1c (<5.0%).
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close